| Literature DB >> 32660604 |
Alicia Cuesta-Gómez1, Patricia Sánchez-Herrera-Baeza2, Edwin Daniel Oña-Simbaña3, Alicia Martínez-Medina4, Carmen Ortiz-Comino4, Carlos Balaguer-Bernaldo-de-Quirós3, Alberto Jardón-Huete3, Roberto Cano-de-la-Cuerda1.
Abstract
BACKGROUND: Dexterity and activities of daily living limitations on the upper limb (UL) represent one of the most common problems in patients with multiple sclerosis (MS). The aim of this study was to evaluate the effectiveness of the specially developed Serious Games that make use of the Leap Motion Controller (LMC) as main user interface for improving UL grip muscle strength, dexterity, fatigue, quality of life, satisfaction and compliance.Entities:
Keywords: Dexterity; Leap motion controller; Multiple sclerosis; Rehabilitation; Serious games; Upper limb; Virtual reality
Mesh:
Year: 2020 PMID: 32660604 PMCID: PMC7359450 DOI: 10.1186/s12984-020-00718-x
Source DB: PubMed Journal: J Neuroeng Rehabil ISSN: 1743-0003 Impact factor: 4.262
Fig. 1Set of video games designed for the Leap Motion® System used in this protocol. Screen translation: Please adjust the distance and thickness of the keys and the height of the hands as you want, using the corresponding bars. Height, distance and thickness of the keys
Fig. 2a Piano Game. Screen translation: Piano: both hands. b Reach Game. Screen translation: Reach: right hand. c Grab Game. Screen translation: Grab: right hand. You caught it! without opening your hand, transport the cube to the red point. d Pinch Game. Screen translation: Pinch: right hand. e. Flip Game. Screen translation: Flip: both hands. Please place your hand in the corresponding blue table position
Patient features
| Groups (n) | Age (years) Mean (±Standard deviation) | Gender | More affected side | Type of MS | Disease duration (years) | EDSS |
|---|---|---|---|---|---|---|
| 49.86 (±2.46) | 7 Male 9 Female | 7 Right 9 Left | RRMS: 4 SPMS: 8 PPMS: 4 | 15.20 (±2.43) | 5.43 (±0.31) | |
| 42.66 (±3.14) | 5 Male 9 Female | 6 Right 8 Left | RRMS: 7 SPMS: 5 PPMS: 2 | 10.91 (±2.19) | 5.45 (±0.36) |
EDSS Kurtzke Expanded Disability Status Scale; MS Multiple Sclerosis; PP-MS Primary-Progressive MS; RR-MS Relapsing-Remitting MS; SP-MS Secondary-Progressive MS. Data are expressed as mean (±Standard deviation)
Comparison of outcome scores (Intragroup analysis)
| Variable | Pre | Post | Follow up | Intragroup | Two-paired comparisons | |||
|---|---|---|---|---|---|---|---|---|
| Median (Interquartile range) | ||||||||
| Pre vs. Post | Pre vs. Follow up | Post vs. Follow up | ||||||
| Jamar More affected | Experimental group | 17.00 (20.34) | 21.00 (13.33) | 17.33 (12.00) | .038 | .099 | .670 | .092 |
| Control group | 13.00 (11.00) | 13.00 (10.33) | 13.00 (7.67) | .208 | .070 | .448 | .091 | |
| Jamar Less affected | Experimental group | 21.33 (16.00) | 20.00 (19.67) | 18.33 (16.00) | .011* | .019† | .776 | .002† |
| Control group | 17.00 (11.33) | 16.33 (14.50) | 15.33 (14.00) | .337 | .723 | .123 | .063 | |
| PPT More affected | Experimental group | 7.66 (4.33) | 9.66 (5.33) | 9.00 (4.66) | .015* | .008† | .157 | .055 |
| Control group | 3.33 (8.83) | 3.66 (7.67) | 3.66 (10.50) | .227 | .514 | .204 | .203 | |
| PPT Less affected | Experimental group | 9.33 (3.33) | 10.33 (3.00) | 9.66 (3.34) | .006* | .004† | .220 | .110 |
| Control group | 9.66 (6.33) | 10.00 (11.00) | 10.00 (11.00) | .191 | .384 | .375 | .227 | |
| PPT Both hands | Experimental group | 12.66 (5.33) | 15.33 (8.00) | 14.66 (6.00) | .014* | .005† | .441 | .480 |
| Control group | 9.33 (12.66) | 6.66 (13.67) | 7.33 (12.66) | .966 | .339 | .932 | .496 | |
| PPT Assembly | Experimental group | 15.66 (5.00) | 20.00 (7.33) | 16.66 (7.66) | .002* | .001† | .038† | .094 |
| Control group | 13.33 (18.83) | 10.66 (15.83) | 14.33 (19.17) | .104 | .440 | .128 | .080 | |
| BBT More affected | Experimental group | 40.00 (23.00) | 48.00 (14.00) | 51.00 (9.00) | .002* | .003† | .016† | .779 |
| Control group | 26.00 (31.50) | 28.00 (30.00) | 30.00 (25.00) | .140 | .071 | .090 | .779 | |
| BBT Less affected | Experimental group | 44.00 (18.00) | 48.00 (13.00) | 52.00 (12.00) | .002* | .028† | .002† | .107 |
| Control group | 41.00 (27.00) | 42.00 (36.00) | 48.00 (36.00) | .008* | .007† | .013† | .236 | |
| NHPT More affected | Experimental group | 35.35 (13.09) | 32.03 (19.74) | 28.90 (15.21) | .127 | .334 | .088 | .211 |
| Control group | 60.22 (57.33) | 70.15 (76.02) | 70.15 (70.19) | .122 | .929 | .182 | .236 | |
| NHPT Less affected | Experimental group | 30.62 (16.95) | 29.07 (15.23) | 28.15 (11.10) | .282 | .078 | .053 | .820 |
| Control group | 27.50 (24.06) | 23.31 (19.27) | 25.24 (18.50) | .053 | .138 | .172 | .236 | |
| MSIS-29 physical score | Experimental group | 62.00 (36.00) | 60.00 (22.00) | 63.00 (34.00) | .701 | .233 | .629 | .826 |
| Control group | 55.00 (33.00) | 66.00 (31.00) | 66.00 (34.00) | .917 | .527 | .789 | .372 | |
| MSIS-29 psychological score | Experimental group | 57.77 (28.89) | 64.44 (20.00) | 66.66 (35.56) | .878 | .552 | .780 | .683 |
| Control group | 46.66 (23.33) | 51.11 (16.67) | 48.00 (28.28) | .186 | .086 | .723 | .210 | |
| FFS | Experimental group | 58.73 (37.88) | 63.49 (42.86) | 58.73 (17.46) | .819 | .363 | .629 | .712 |
| Control group | 57.14 (26.19) | 58.73 (17.47) | 58.73 (30.17) | .679 | .700 | .752 | .959 | |
PPT Purdue Pegboard Test; BBT box and block test; NHPT Nine Hole Peg Test. MSIS-29 Multiple Sclerosis Impact Scale. FSS Fatigue Severity Scale. Data are expressed as median and interquartile range. *p value < 0.016 using the Friedman test (after Bonferroni correction) and †p value < 0.05 using the Wilcoxon test for related samples
Comparison of outcome scores between the experimental and control group (Intergroup analysis)
| Variable | Experimental group | Control group | Experimental vs. Control group | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Follow up | Pre | Post | Follow up | Pre | Post | Follow up | |
| Jamar More affected | 17.00 (20.34) | 21.00 (13.33) | 17.33 (12.00) | 13.00 (11.00) | 13.00 (10.33) | 13.00 (7.67) | 0.259 | 0.092 | 0.097 |
| Jamar Less affected | 21.33 (16.00) | 20.00 (19.67) | 18.33 (16.00) | 17.00 (11.33) | 16.33 (14.50) | 15.33 (14.00) | 0.982 | 0.181 | 0.278 |
| PPT More affected | 7.66 (4.33) | 9.66 (5.33) | 9.00 (4.66) | 3.33 (8.83) | 3.66 (7.67) | 3.66 (10.50) | 0.133 | 0.032* | 0.221 |
| PPT Less affected | 9.33 (3.33) | 10.33 (3.00) | 9.66 (3.34) | 9.66 (6.33) | 10.00 (11.00) | 10.00 (11.00) | 0.729 | 0.277 | 0.746 |
| PPT Both hands | 12.66 (5.33) | 15.33 (8.00) | 14.66 (6.00) | 9.33 (12.66) | 6.66 (13.67) | 7.33 (12.66) | 0.071 | 0.019* | 0.067 |
| PPT Assembly | 15.66 (5.00) | 20.00 (7.33) | 16.66 (7.66) | 13.33 (18.83) | 10.66 (15.83) | 14.33 (19.17) | 0.332 | 0.008* | 0.460 |
| BBT More affected | 40.00 (23.00) | 48.00 (14.00) | 51.00 (9.00) | 26.00 (31.50) | 28.00 (30.00) | 30.00 (25.00) | 0.068 | 0.036* | 0.010* |
| BBT Less affected | 44.00 (18.00) | 48.00 (13.00) | 52.00 (12.00) | 41.00 (27.00) | 42.00 (36.00) | 48.00 (36.00) | 0.356 | 0.549 | 0.321 |
| NHPT More affected | 35.35 (13.09) | 32.03 (19.74) | 28.90 (15.21) | 60.22 (57.33) | 70.15 (76.02) | 70.15 (70.19) | 0.122 | 0.069 | 0.011* |
| NHPT Less affected | 30.62 (16.95) | 29.07 (15.23) | 28.15 (11.10) | 27.50 (24.06) | 23.31 (19.27) | 25.24 (18.50) | 0.278 | 0.160 | 0.205 |
| MSIS-29 physical score | 62.00 (36.00) | 60.00 (22.00) | 63.00 (34.00) | 55.00 (33.00) | 66.00 (31.00) | 66.00 (34.00) | 0.381 | 0.475 | 0.628 |
| MSIS-29 psychological score | 57.77 (28.89) | 64.44 (20.00) | 66.66 (35.56) | 46.66 (23.33) | 51.11 (16.67) | 48.00 (28.28) | 0.075 | 0.127 | 0.174 |
| FSS | 58.73 (37.88) | 63.49 (42.86) | 58.73 (17.46) | 57.14 (26.19) | 58.73 (17.47) | 58.73 (30.17) | 0.729 | 0.644 | 0.963 |
PPT Purdue Pegboard Test; BBT box and block test; NHPT Nine Hole Peg Test. MSIS-29 Multiple Sclerosis Impact Scale. FSS Fatigue Severity Scale. Data are expressed as median and interquartile range. *p value < 0.05 using Mann-Whitney test for not related sample